Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech venture capital
Biotech
Fierce Biotech Fundraising Tracker '26: Immutrin, R1 & more
Welcome to Fierce Biotech’s Fundraising Tracker for 2026.
Will Maddox
,
Darren Incorvaia
,
James Waldron
,
Gabrielle Masson
Mar 24, 2026 5:40am
Crossbow hits $77M series B round to bankroll quiver of T-Bolts
Mar 18, 2026 10:50am
R1 debuts with $77.5M to advance kidney disease treatment
Mar 17, 2026 7:00am
Breakout Ventures launches $114M AI-focused fund
Mar 10, 2026 7:00am
VC firm to open 30K-square-foot incubator in Salt Lake City
Mar 5, 2026 10:00am
Biotech's top money raisers: 2025
Mar 2, 2026 6:30am
